BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Karunakaran KP, Yu H, Jiang X, Chan QWT, Foster LJ, Johnson RM, Brunham RC. Discordance in the Epithelial Cell-Dendritic Cell Major Histocompatibility Complex Class II Immunoproteome: Implications for Chlamydia Vaccine Development. J Infect Dis 2020;221:841-50. [PMID: 31599954 DOI: 10.1093/infdis/jiz522] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Mayer RL, Impens F. Immunopeptidomics for next-generation bacterial vaccine development. Trends Microbiol 2021:S0966-842X(21)00121-9. [PMID: 34030969 DOI: 10.1016/j.tim.2021.04.010] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 3.5] [Reference Citation Analysis]
2 Johnson RM, Olivares-Strank N, Peng G. A Class II-Restricted CD8γ13 T-Cell Clone Protects During Chlamydia muridarum Genital Tract Infection. J Infect Dis 2020;221:1895-906. [PMID: 31899500 DOI: 10.1093/infdis/jiz685] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
3 Kumar V, Kancharla S, Kolli P, Jena M. Reverse vaccinology approach towards the in-silico multiepitope vaccine development against SARS-CoV-2. F1000Res 2021;10:44. [PMID: 33841800 DOI: 10.12688/f1000research.36371.1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]